---
title: "Amgen Says Strongly Disagrees With FDA'S Proposal To Withdraw Tavneos From The U.S. Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293755129.md"
datetime: "2026-07-24T12:13:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293755129.md)
  - [en](https://longbridge.com/en/news/293755129.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293755129.md)
generator: "portal-rs"
---

# Amgen Says Strongly Disagrees With FDA'S Proposal To Withdraw Tavneos From The U.S. Market

July 24 (Reuters) - Amgen Inc (AMGN.O) : \* AMGEN : SUBMITS DATA TO FDA SEEKING HEARING ON TAVNEOS AVACOPAN IN RESPONSE TO WITHDRAWAL PROPOSAL \* AMGEN INC: STRONGLY DISAGREES WITH FDA'S PROPOSAL TO WITHDRAW TAVNEOS FROM THE U.S. MARKET Source text: Further company coverage: (AMGN.O)

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)

## Related News & Research

- [UK regulator suspends Amgen's Tavneos for new patients over unreliable data](https://longbridge.com/en/news/297642592.md)
- [Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of "Hold" by Brokerages](https://longbridge.com/en/news/297390790.md)
- [8,321 Shares in Amgen Inc. $AMGN Bought by Glenview Trust Co](https://longbridge.com/en/news/297400065.md)
- [Strait & Sound Wealth Management LLC Invests $1.92 Million in Amgen Inc. $AMGN](https://longbridge.com/en/news/297400046.md)
- [TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS | AMGN Stock News](https://longbridge.com/en/news/297131330.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**